Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in BCTX — BriaCell Therapeutics Corp.

CIK 1446194 BALA CYNWYD, PA

Position in BCTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
114,522
+379.4% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCTX Over Time

Shares Held

Position Value (USD)

Derivatives in BCTX

reported options exposure · as of Jun 30, 2024
CallValue
$83,676
CallShares
7,340
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. BCTX ranks #347 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2024-12-31 $28,341 50,609
2024-09-30 $17,234 13,899
2024-06-30 $14,086 12,357
2024-06-30 $83,676 73,400
2024-03-31 $35,341 12,357
2024-03-31 $378,664 132,400
2024-03-31 $44,902 15,700
2023-12-31 $773,370 132,200
2023-12-31 $364,583 62,322
2023-09-30 $398,125 63,700
2023-09-30 $325,418 52,067